Emanuele Ostuni, PhD

Emanuele Ostuni, PhD

Emanuele is Head of Europe for Cell and Gene Therapies at Novartis Oncology, where he oversees the commercialization of this portfolio in Europe. 

Emanuele is with Novartis since 2012.  He joined the Sandoz Division with the Global Strategy Team, where he managed the collaborations with Novartis Pharmaceuticals and Alcon. He then became Head of Specialty and Hospital Franchises, Central/Eastern Europe, where he developed a specialty expansion strategy.  Emanuele later served as Business Unit Head, Rx in Romania. In this role he grew the team to drive the expansion into CNS, respiratory, and rheumatology franchises. 

Prior to joining Novartis in Europe he was based in the USA where he was Vice President of Business Development at Nano Terra, Engagement Manager at McKinsey & Co and a Senior Research Investigator at Surface Logix, where he helped to establish the company’s drug discovery platform.

Emanuele holds a PhD in Physical Chemistry from Harvard University and BS and MS degrees in chemistry from Georgetown University.